Structures by: Seela F.
Total: 52
C9H12N6O4
C9H12N6O4
Organic & biomolecular chemistry (2005) 3, 9 1714-1718
a=9.7754(7)Å b=9.7754(7)Å c=20.3627(19)Å
α=90.00° β=90.00° γ=120.00°
7-Iodo-5-aza-7-deazaguanosine
C10H12IN5O5
Acta Crystallographica Section C (2020) 76, 5 513-523
a=9.1086(2)Å b=6.3149(2)Å c=11.0428(3)Å
α=90° β=95.5850(10)° γ=90°
9-(2-deoxy-α-D-erythro-pentofuranosyl)-8-aza-7-deazaadenine
C10H13N5O3
Acta Crystallographica Section C (1999) 55, 11 1947-1950
a=5.8690(6)Å b=10.8869(13)Å c=17.5477(14)Å
α=90.00° β=90.00° γ=90.00°
8-Aza-7-deaza-2'-deoxyadenosine
C10H13N5O3
Acta Crystallographica Section C (1999) 55, 11 1947-1950
a=7.2420(14)Å b=10.862(2)Å c=14.2846(16)Å
α=90.00° β=90.00° γ=90.00°
7-Deaza-2'-deoxyisoguanosine
C11H14N4O4,H2O
Acta Crystallographica Section C (1999) 55, 8 1335-1337
a=6.8040(8)Å b=10.0373(10)Å c=18.682(2)Å
α=90.00° β=90.00° γ=90.00°
9-(2-Deoxy-α-D-ribofuranosyl)-7-iodo-7-deazaadenine
C11H13IN4O3
Acta Crystallographica Section C (1999) 55, 9 1560-1562
a=8.5158(8)Å b=7.0115(6)Å c=10.9335(13)Å
α=90.00° β=97.375(12)° γ=90.00°
4-nitro-1-(β-D-ribofuranosyl)-1H-indazole
C12H13N3O6
Acta Crystallographica Section C (2004) 60, 1 o94-o97
a=5.8912(11)Å b=10.0825(12)Å c=11.0998(17)Å
α=90° β=102.821(15)° γ=90°
4-nitro-2-(β-D-ribofuranosyl)-2H-indazole
C12H13N3O6
Acta Crystallographica Section C (2004) 60, 1 o94-o97
a=4.9355(13)Å b=35.936(5)Å c=7.1833(9)Å
α=90° β=99.311(18)° γ=90°
C11H12N6O4
C11H12N6O4
Acta Crystallographica Section C (2004) 60, 8 o566-o568
a=6.8229(5)Å b=8.9565(11)Å c=20.310(6)Å
α=90.00° β=90.00° γ=90.00°
8-Aza-1,3dideaza-2'-deoxyadenosine
C11H14N4O3
Acta Crystallographica Section C (2001) 57, 5 660-662
a=6.9590(10)Å b=8.5640(10)Å c=18.734(3)Å
α=90.00° β=90.00° γ=90.00°
2'-Deoxy-5-methylisocytidine
C10H15N3O4
Acta Crystallographica Section C (2000) 56, 8 989-991
a=16.611(3)Å b=16.611(3)Å c=10.6471(13)Å
α=90.00° β=90.00° γ=120.00°
C12H13N3O5
C12H13N3O5
Acta Crystallographica Section C (2004) 60, 6 o387-o389
a=6.7444(12)Å b=11.718(3)Å c=15.734(2)Å
α=90.00° β=90.00° γ=90.00°
4-amino-1-(2-deoxy-β-D-erythro-pentofuranosyl)-6-methylsulfanyl-1H- pyrazolo[3,4-d]pyrimidine
C11H15N5O3S
Acta Crystallographica Section C (2005) 61, 9 o562-o564
a=9.4470(16)Å b=6.6805(9)Å c=10.6102(17)Å
α=90.00° β=98.563(9)° γ=90.00°
1-(2-deoxy-β-D-<i>erythro</i>-pentofuranosyl)-5-(prop-1-ynyl)-pyrimidin- 2,4(1<i>H</i>,3<i>H</i>)-dione
C12H14N2O5
Acta Crystallographica Section C (2009) 65, 12 o645-o648
a=5.6201(4)Å b=11.3645(9)Å c=19.0281(16)Å
α=90.00° β=96.659(4)° γ=90.00°
1,<i>N</i>^6^-Etheno-2'-deoxytubercidin hemihydrate
2(C13H14N4O3),H2O
Acta Crystallographica Section C (2011) 67, 3 o111-o114
a=19.6476(12)Å b=5.2979(3)Å c=26.3354(16)Å
α=90.00° β=106.865(3)° γ=90.00°
6-Aza-2'-deoxy-2'-arabinofluorouridine
C8H10FN3O5
Acta Crystallographica Section C (2004) 60, 12 o884-o886
a=4.9302(9)Å b=10.993(2)Å c=9.4360(16)Å
α=90.00° β=98.62(2)° γ=90.00°
4-Amino-5-cyclopropyl-7-(2-deoxy-β-<i>D</i>-<i>erythro</i>-pentofuranosyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine
C14H18N4O3
Acta Crystallographica Section C (2014) 70, 12
a=5.0104(3)Å b=13.0418(7)Å c=20.8610(9)Å
α=90.00° β=90.00° γ=90.00°
5-Ethynyl-2'-deoxycytidine
C11H13N3O4
Acta Crystallographica Section C (2012) 68, 10 o395-o398
a=7.8754(6)Å b=8.1504(6)Å c=10.0893(7)Å
α=108.637(3)° β=96.327(3)° γ=104.562(3)°
9-(2-deoxy-α-D-ribofuranosyl)-5-aza-7-deazaguanine
C10H13N5O4,H2O
Acta Crystallographica Section C (2002) 58, 3 o142-o144
a=8.5397(14)Å b=7.1025(14)Å c=10.7187(16)Å
α=90.00° β=107.460(13)° γ=90.00°
1-(2-deoxy-β-D-erythro-furanosyl)-1H-pyrazolo[3,4-d]pyrimidine
C10H12N4O3
Acta Crystallographica Section C (2002) 58, 10 o593-o595
a=6.9306(8)Å b=11.1084(15)Å c=13.7591(11)Å
α=90.00° β=90.00° γ=90.00°
2-(2-deoxy-β-D-erythro-furanosyl)-2H-pyrazolo[3,4-d]pyrimidine
C10H12N4O3
Acta Crystallographica Section C (2002) 58, 10 o593-o595
a=4.9396(7)Å b=13.1528(14)Å c=8.1780(12)Å
α=90.00° β=102.772(9)° γ=90.00°
C9H14N4O4
C9H14N4O4
Acta Crystallographica Section C (2003) 59, 4 o194-o196
a=8.682(2)Å b=7.8835(16)Å c=8.998(3)Å
α=90.00° β=118.088(18)° γ=90.00°
3-Bromo-1-(2-deoxy-β-D-erythro-pentofuranosyl)-1H- pyrazolo[3,4-d]pyrimidine-4,6-diamine
C10H13BrN6O3
Acta Crystallographica Section C (2005) 61, 2 o67-o69
a=7.5939(10)Å b=9.2822(18)Å c=18.164(2)Å
α=90.00° β=90.00° γ=90.00°
8-Aza-7-deaza-7-propynyladenosine methanol solvate
C13H15N5O4,CH4O
Acta Crystallographica Section C (2005) 61, 4 o195-o197
a=7.3269(11)Å b=10.0790(16)Å c=21.813(3)Å
α=90.00° β=90.00° γ=90.00°
7-Fluoro-2'-deoxytubercidin
C11H13FN4O3
Acta Crystallographica Section C (2005) 61, 6 o408-o410
a=6.8780(18)Å b=10.144(2)Å c=17.283(2)Å
α=90.00° β=90.00° γ=90.00°
4-Amino-7-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-fluoro- 7H-pyrrolo[2,3-d]pyrimidine
C11H12F2N4O3
Acta Crystallographica Section C (2006) 62, 4 o231-o233
a=5.7355(6)Å b=9.8374(13)Å c=10.9428(13)Å
α=90.00° β=97.856(9)° γ=90.00°
2'-Deoxy-7-propynyl-7-deazaadenosine
C14H16N4O3
Acta Crystallographica Section C (2006) 62, 5 o246-o248
a=6.5812(11)Å b=10.5084(13)Å c=19.216(2)Å
α=90.00° β=90.00° γ=90.00°
2,4-diamino-7-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-bromo-7H- pyrrolo[2,3-d]pyrimidine
C11H13BrFN5O3
Acta Crystallographica Section C (2007) 63, 10 o600-o602
a=7.7618(14)Å b=9.688(2)Å c=17.707(3)Å
α=90.00° β=90.00° γ=90.00°
3-Bromo-1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-4H- pyrazolo[3,4-d]pyrimidin-4-one
C10H11BrFN5O4,C3H6O,H2O
Acta Crystallographica Section C (2003) 59, 7 o406-o408
a=10.8449(10)Å b=7.3649(9)Å c=11.1537(17)Å
α=90.00° β=90.182(8)° γ=90.00°
7-Deaza-7-(propynyl)-2'-deoxyguanosine
C14H16N4O4
Acta Crystallographica Section C (2004) 60, 7 o489-o491
a=4.799(2)Å b=13.601(3)Å c=11.014(3)Å
α=90.00° β=100.49(3)° γ=90.00°
1,7-Dideaza-2'-deoxy-6-nitronebularine
C12H13N3O5
Acta Crystallographica Section C (2013) 69, 8 892-895
a=6.4621(4)Å b=9.1450(5)Å c=20.2969(12)Å
α=90.00° β=90.00° γ=90.00°
4-amino-1-(2-deoxy-β-D-erythro-pentofuranosyl)- 3-iodo-1H-pyrazolo[3,4-d]pyrimidine
C10H12IN5O3
Acta Crystallographica Section C (2000) 56, 4 489-491
a=9.259(3)Å b=7.2787(10)Å c=9.767(3)Å
α=90.00° β=110.29(2)° γ=90.00°
4-amino-3-bromo-1-(2-deoxy-β-D-erythro-pentofuranosyl)- 1H-pyrazolo[3,4-d]pyrimidine
C10H12BrN5O3
Acta Crystallographica Section C (2000) 56, 4 489-491
a=9.0930(9)Å b=7.2595(10)Å c=9.6369(19)Å
α=90.00° β=109.362(11)° γ=90.00°
<i>N</i>^1^-(2'-deoxyribofuranoside) of 3-iodo-5-nitroindole
C13H13IN2O5
Acta Crystallographica Section C (2009) 65, 3 o100-o102
a=17.549(3)Å b=7.0981(10)Å c=10.9242(19)Å
α=90.00° β=90.00° γ=90.00°
4-amino-5-cyano-1-(β-D-ribofuranosyl)-7<i>H</i>- pyrrolo[2,3-<i>d</i>]pyrimidine hemihydrate
C12H13N5O4,0.5(H2O)
Acta Crystallographica Section C (2009) 65, 9 o431-o434
a=9.5382(7)Å b=9.9155(6)Å c=28.2197(19)Å
α=90.00° β=90.00° γ=90.00°
2-amino-8-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)imidazo[1,2-<i>a</i>]- 1,3,5-triazin-4(8<i>H</i>)-one monohydrate
C10H12FN5O4,H2O
Acta Crystallographica Section C (2010) 66, 4 o194-o197
a=7.3752(6)Å b=6.3516(4)Å c=13.8654(11)Å
α=90.00° β=103.648(4)° γ=90.00°
7-Deaza-2,8-diazaadenosine
C9H12N6O4
Acta Crystallographica Section C (2006) 62, 7 o379-o381
a=9.7859(7)Å b=9.7859(7)Å c=20.3813(14)Å
α=90.00° β=90.00° γ=120.00°
2'-Deoxy-5-propynylcytidine
C12H15N3O4
Acta Crystallographica Section C (2007) 63, 1 o54-o57
a=8.3908(7)Å b=9.0698(8)Å c=9.7303(10)Å
α=64.734(5)° β=71.721(10)° γ=88.198(11)°
2'-Deoxy-2-fluorotubercidin
C11H13FN4O3
Acta Crystallographica Section C (2007) 63, 2 o96-o98
a=5.5515(8)Å b=12.6547(12)Å c=17.0171(19)Å
α=90.00° β=90.00° γ=90.00°
4-chloro-7-(2-deoxy-β-D-erythro-pentofuranosyl)- 7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine
C11H14ClN5O3
Acta Crystallographica Section C (2006) 62, 10 o593-o595
a=7.637(2)Å b=9.4576(17)Å c=17.632(4)Å
α=90.00° β=90.00° γ=90.00°
2'-deoxyimmunosine
C10H12N4O5S
Acta Crystallographica Section C (2007) 63, 9 o549-o551
a=5.2347(10)Å b=7.1855(13)Å c=8.9972(16)Å
α=110.756(12)° β=96.827(13)° γ=99.511(19)°
4-amino-2-(2-O-methyl-β-D-ribofuranosyl)-2H-pyrazolo[3,4-d]pyrimidine monohydrate
C11H15N5O4,H2O
Acta Crystallographica Section C (2006) 62, 2 o79-o81
a=17.263(2)Å b=7.5673(7)Å c=10.4757(8)Å
α=90.00° β=93.128(8)° γ=90.00°
C12H15N5O3,H2O
C12H15N5O3,H2O
Acta Crystallographica Section C (2005) 61, 1 o60-o62
a=6.6513(8)Å b=9.603(5)Å c=21.481(3)Å
α=90.00° β=90.00° γ=90.00°
7-Deaza-2'-deoxyguanosine
C11H14N4O4
Acta Crystallographica Section C (2005) 61, 3 o151-o153
a=5.4146(12)Å b=10.969(2)Å c=19.968(4)Å
α=90.00° β=90.00° γ=90.00°
6-aza-2'-deoxyuridine
C8H11N3O5
Acta Crystallographica Section C (2007) 63, 3 o173-o176
a=7.8817(17)Å b=8.6832(11)Å c=14.5715(15)Å
α=90.00° β=90.00° γ=90.00°
N^3^-anisoyl-6-aza-2'-deoxyuridine
C16H17N3O7
Acta Crystallographica Section C (2007) 63, 3 o173-o176
a=7.452(3)Å b=9.1170(10)Å c=24.780(3)Å
α=90.00° β=90.00° γ=90.00°
4-amino-5-fluoro-7-(β-D-ribofuranosyl)-7<i>H</i>- pyrrolo[2,3-<i>d</i>]pyrimidine
C11H13FN4O4
Acta Crystallographica Section C (2008) 64, 5 o293-o295
a=4.9394(13)Å b=14.6718(19)Å c=16.8181(16)Å
α=90.00° β=90.00° γ=90.00°
7-Deaza-2'-deoxyinosine
C11H13N3O4
Acta Crystallographica Section C (2008) 64, 8 o417-o419
a=19.9633(6)Å b=5.2733(2)Å c=11.2390(4)Å
α=90.00° β=106.109(2)° γ=90.00°
7-Amino-1-(2-deoxy-β-<i>erythro</i>-pentofuranosyl)-1<i>H</i>-1,2,3- triazolo[4,5-<i>d</i>]pyrimidine
C9H12N6O3
Acta Crystallographica Section C (2010) 66, 11 o561-o564
a=7.1469(3)Å b=8.7025(4)Å c=9.1100(4)Å
α=90.00° β=104.056(2)° γ=90.00°
4-amino-1-(2-deoxy-β-D-<i>erythro</i>- pentofuranosyl)-5-[6-(1-benzyl-1<i>H</i>-1,2,3-triazol-4-yl)hex-1- ynyl]pyrimidin-2(1<i>H</i>)-one
C24H28N6O4
Acta Crystallographica Section C (2012) 68, 4 o174-o178
a=12.525(6)Å b=15.051(7)Å c=12.719(6)Å
α=90.00° β=106.241(10)° γ=90.00°
C10H12IN5O4
C10H12IN5O4
The Journal of organic chemistry (2019) 84, 21 13313-13328
a=4.9620(2)Å b=13.1568(6)Å c=10.7648(5)Å
α=90° β=96.6740(10)° γ=90°
C11H15BrN4O5
C11H15BrN4O5
Journal of the American Chemical Society (2005) 127, 7739-7751
a=6.8229(9)Å b=10.7754(18)Å c=18.558(3)Å
α=90.00° β=90.00° γ=90.00°